NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1003 coverGLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION Volume 1003 published December 2003
Ann. N.Y. Acad. Sci. 1003: 102 (2003). doi: 10.1196/annals.1300.007
Copyright © 2003 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by LEWIS, D. A.
Articles by SWEET, R. A.
Search for Related Content
PubMed
PubMed Citation
Articles by LEWIS, D. A.
Articles by SWEET, R. A.
Altered Cortical Glutamate Neurotransmission in Schizophrenia

Evidence from Morphological Studies of Pyramidal Neurons

DAVID A. LEWISa,b, LEISA A. GLANTZc, JOSEPH N. PIERRIa AND ROBERT A. SWEETa

Departments of aPsychiatry and bNeuroscience, University of Pittsburgh, Pennsylvania 15213, USA
cDepartment of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599, USA

Address for correspondence: David A. Lewis, M.D., Department of Psychiatry, University of Pittsburgh, 3811 O'Hara Street, W1651 BST, Pittsburgh, PA 15213. Voice: 412-624-3934; fax: 412-624-9910.
lewisda{at}msx.upmc.edu
Ann. N.Y. Acad. Sci. 1003: 102-112 (2003).

Multiple lines of evidence from pharmacological, neuroimaging, and postmortem studies implicate disturbances in cortical glutamate neurotransmission in the pathophysiology of schizophrenia. Given that pyramidal neurons are the principal source of cortical glutamate neurotransmission, as well as the targets of the majority of cortical glutamate-containing axon terminals, understanding the nature of altered glutamate neurotransmission in schizophrenia requires an appreciation of both the types of pyramidal cell abnormalities and the specific class(es) of pyramidal cells that are affected in the illness. In this chapter, we review evidence indicating that a subpopulation of pyramidal neurons in the dorsolateral prefrontal cortex exhibits reductions in dendritic spine density, a marker of the number of excitatory inputs, and in somal volume, a measure correlated with a neuron's dendritic and axonal architecture. Specifically, pyramidal neurons located in deep layer 3 of the dorsolateral prefrontal cortex and that lack immunoreactivity for nonphosphorylated neurofilament protein may be particularly involved in the pathophysiology of schizophrenia. The presence of similar changes in pyramidal neurons located in deep layer 3 of auditory association cortex suggests that a shared property, which remains to be determined, confers cell type-specific vulnerability to a subpopulation of cortical glutamatergic neurons in schizophrenia.

Key Words: schizophrenia • pyramidal neurons • dorsolateral prefrontal cortex • deep layer 3




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
C. H. Large
Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
J Psychopharmacol, May 1, 2007; 21(3): 283 - 301.
[Abstract] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. L. Marquis, A. L. Sabb, S. F. Logue, J. A. Brennan, M. J. Piesla, T. A. Comery, S. M. Grauer, C. R. Ashby Jr., H. Q. Nguyen, L. A. Dawson, et al.
WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity
J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 486 - 496.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
K. TAKAO and T. MIYAKAWA
Investigating Gene-to-Behavior Pathways in Psychiatric Disorders: The Use of a Comprehensive Behavioral Test Battery on Genetically Engineered Mice
Ann. N.Y. Acad. Sci., November 1, 2006; 1086(1): 144 - 159.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. K. Lipska, T. Peters, T. M. Hyde, N. Halim, C. Horowitz, S. Mitkus, C. S. Weickert, M. Matsumoto, A. Sawa, R. E. Straub, et al.
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs
Hum. Mol. Genet., April 15, 2006; 15(8): 1245 - 1258.
[Abstract] [Full Text] [PDF]



footerLeft footerRight